PODD News Alert Insulet Corp (PODD) 46.24 12/25/2014 05:26:4

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Insulet Corp (PODD) 46.24 $PODD

Global Continuous Glucose Monitoring System 2014 - 2020
M2 - Fri Dec 12, 2:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/ccxjt3/global_continuous) has announced the addition of the "Global Continuous Glucose Monitoring System 2014 - 2020" report to their offering. Emergence of continuous glucose monitoring systems is a major breakthrough in the glucose monitoring for diabetic patients. Medtronic and Dexcom are the only major players in this industry followed by Abbott in few regions. Companies are focusing more on research and development before introducing their products in the market. CGMS are highly regulated and go through strict tests before being approved. CGM manufacturers have faced competition from Finger based self-monitoring blood glucose devices. SMBG devices are cheaper and easy to use and are easily approved by the authorities. SMBG has more number of players and larger market share. However, CGM systems have been able to make a good market entry in the U.S. and are following the trend in other territories. . CGM system market has seen good growth rates in past three years. Medtronic and Dexcom have introduced new systems which have witnessed lower frequency of errors. The MARD value for new sensors has decreased, new devices need lesser calibrations per day and most of the devices are approved for pediatric use. This has led to 50-60 percent jump in the revenues of some manufacturers. Global Continuous Glucose Monitoring System Market - CGM Market - Real Time Monitoring - Integrated Insulin Pumps - Blood Glucose - Manufacturers - Global Health - IPRO Glucose - MARD - SMBG - Growing Diabetic Population - Type 1 & 2 Diabetes - Nocturnal Hypoglycemia Key Topics Covered: Chapter 1. Executive Summary Chapter 2. Market Overview Chapter 3. Market Determinants Chapter 4. Sector Analysis: Diabetes Care Chapter 5. Cgms Market By Devices Chapter 6. By Application Chapter 7. Competitive Intelligence Chapter 8. Market Share Analysis Chapter 9. Geographical Analysis Chapter 10. Corporate Profile: Benchmark Study - Medtronic Inc. - Dexcom - Abbott - Johnson And Johnson (J&J) (Animas Corp) - Insulet Corp - Tandem Diabetes - Echo Therapeutics For more information visit http://www.researchandmarkets.com/research/cc...continuous
ECTE: 1.50 (unch), JNJ: 104.59 (+0.31), PODD: 46.24 (+0.90), MDT: 74.08 (+0.31)

Insulet Up 23.2% Since SmarTrend Uptrend Call (PODD)
Comtex SmarTrend(R) - Mon Dec 08, 9:49AM CST
SmarTrend identified an Uptrend for Insulet (NASDAQ ODD) on September 24th, 2014 at $37.83. In approximately 3 months, Insulet has returned 23.16% as of today's recent price of $46.59.
PODD: 46.24 (+0.90)

DexCom CEO Terry Gregg Explains 50% YTD Stock Leap, Plans for 2015
at The Street - Wed Dec 03, 3:54PM CST
DexCom shares are up over 50% for the year on four FDA approvals. CEO Terry Gregg says technology is driving its products to the forefront.
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), PODD: 46.24 (+0.90), DXCM: 54.94 (+0.99), TNDM: 12.98 (-0.02), AAPL: 112.01 (-0.53)

Next-Generation OmniPod Pumping Up Profitability At Insulet Corp.
Cory Renauer - Seeking Alpha - Wed Dec 03, 1:26PM CST
I'm beginning coverage of Insulet Corporation (NASDAQ: PODD ) with a somewhat buy recommendation. The long case is largely based on rapid revenue growth, expanding margins, and a potential takeover. When recently appointed CEO Patrick Sullivan took...
PODD: 46.24 (+0.90)

Insulet Has Returned 19.7% Since SmarTrend Recommendation (PODD)
Comtex SmarTrend(R) - Mon Dec 01, 9:23AM CST
SmarTrend identified an Uptrend for Insulet (NASDAQ ODD) on September 24th, 2014 at $37.83. In approximately 2 months, Insulet has returned 19.67% as of today's recent price of $45.27.
PODD: 46.24 (+0.90)

Insulet Corporation to Present at Upcoming Investor Conferences
Marketwired - Mon Nov 24, 3:15PM CST
Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod(R) Insulin Management System, plans to participate in the following upcoming investor conferences:
PODD: 46.24 (+0.90)

Insulet Earnings Review: 19 Days after Announcement Shares Up 12.4% (PODD)
Comtex SmarTrend(R) - Mon Nov 24, 8:45AM CST
Two weeks ago on November 5th, 2014 Insulet (NASDAQ ODD) reported earnings and analysts, on average, expected a loss of $0.01 on sales of $75.3 million. Insulet actually reported a loss of $0.19 per share on sales of $75.0 million, missing EPS estimates by $0.18 and matching revenue estimates. Shares of Insulet have climbed from $40.27 to $45.26, representing a gain of 12.4% since the company reported earnings 19 days ago.
PODD: 46.24 (+0.90)

Insulet Up 19.6% Since SmarTrend Uptrend Call (PODD)
Comtex SmarTrend(R) - Fri Nov 21, 4:52PM CST
SmarTrend identified an Uptrend for Insulet (NASDAQ ODD) on September 24th, 2014 at $37.83. In approximately 2 months, Insulet has returned 19.64% as of today's recent price of $45.26.
PODD: 46.24 (+0.90)

Post Earnings Update: Insulet Has Climbed 12.2% Higher in Past Week (PODD)
Comtex SmarTrend(R) - Mon Nov 17, 2:58PM CST
12 days ago, on November 5th, 2014, Insulet (NASDAQ ODD) reported its earnings. Analysts, on average, expected a loss of $0.01 per share on sales of $75.3 million. The company actually reported a loss of $0.19 per share on sales of $75.0 million, missing EPS estimates by $0.18 and matching revenue estimates. Since the company's report, shares of Insulet have risen from $40.27 to $45.17, representing a gain of 12.2% in the past 12 days.
PODD: 46.24 (+0.90)

Uptrend Call Working As Insulet Stock Rises 20.9% (PODD)
Comtex SmarTrend(R) - Fri Nov 14, 11:12AM CST
SmarTrend identified an Uptrend for Insulet (NASDAQ ODD) on September 24th, 2014 at $37.83. In approximately 2 months, Insulet has returned 20.86% as of today's recent price of $45.72.
PODD: 46.24 (+0.90)

Global Insulin Delivery Devices Market Outlook 2018
M2 - Thu Nov 13, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/ttg7ws/global_insulin) has announced the addition of the "Global Insulin Delivery Devices Market Outlook 2018" report to their offering. In 2013, a total of 382 Million People had diabetes and by 2030 this number is expected to rise to 552 Million. This finding by the International Diabetes Federation (IDF) and similar results from studies done by organizations of repute such as WHO, CDC, NHS, etc., suggest that a huge patient population exists in the diabetes market. In 2013, health expenditure on diabetes accounted for around 10% of the total health expenditure globally. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of this current study. In this latest research study Global Insulin Delivery Devices Market Outlook 2018, the analysts identified the market dynamics in various important regions to highlight the areas offering promising opportunities to companies for boosting their growth. Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of the delivery devices market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment's growth, and the future outlook of the segments. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Global Insulin Market Overview to 2018 4. Industry Trends and Drivers 5. Key Market Restraints 6. Global Insulin Delivery Devices Market Outlook to 2018 7. Insulin Delivery Devices: Current and Future Outlook to 2018 8. Emerging Devices 9. Key Players Companies Mentioned: - Abbott Laboratories - B. Braun Melsungen AG - Becton Dickinson - Eli Lilly - F. Hoffmann La Roche - Insulet Corporation - Johnson and Johnson - Medtronic - Novo Nordisk - Sanofi-Aventis - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/tt...al_insulin
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), PODD: 46.24 (+0.90), NVO: 43.80 (+1.08), MDT: 74.08 (+0.31), LLY: 70.16 (+0.42)

Insulet's (PODD) CEO Patrick Sullivan on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 9:41PM CST

PODD: 46.24 (+0.90)

Insulet tops 3Q profit forecasts
Automated Insights - Wed Nov 05, 4:27PM CST
BEDFORD, Mass. (AP) _ Insulet Corp. (PODD) on Wednesday reported a loss of $10.8 million in its third quarter.
PODD: 46.24 (+0.90)

Insulet misses by $0.18, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:13PM CST

PODD: 46.24 (+0.90)

Insulet (PODD) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:25PM CST

PODD: 46.24 (+0.90)

Insulet Corporation Appoints New Chief Financial Officer and Executive Vice President, Human Resources
Marketwired - Wed Nov 05, 3:08PM CST
Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod(R) Insulin Management System, today announced the promotion of Allison Dorval to Chief Financial Officer effective November 6, 2014 and Brad Thomas as Executive Vice President, Human Resources and Organizational Development, effective immediately.
PODD: 46.24 (+0.90)

Insulet Reports Third Quarter 2014 Results
Marketwired - Wed Nov 05, 3:08PM CST
Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod(R) Insulin Management System, today announced financial results for the three and nine months ended September 30, 2014.
PODD: 46.24 (+0.90)

Insulet Shares Up 14.4% Since SmarTrend's Buy Recommendation (PODD)
Comtex SmarTrend(R) - Fri Oct 31, 9:34AM CDT
SmarTrend identified an Uptrend for Insulet (NASDAQ ODD) on September 24th, 2014 at $37.83. In approximately 1 month, Insulet has returned 14.43% as of today's recent price of $43.29.
PODD: 46.24 (+0.90)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 54

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 124

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 149

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 73

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 41

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading

Top 5 Most Recently Viewed Articles

PLAY Airlines Achieves Record Load Factor and Revenue Growth

Updated Category News Views 271

PLAY Airlines Reports Record-Breaking Load Factor for November PLAY Airlines has announced that it carried an impressive 99,393 passengers in the month of November, showcasing its operational efficiency and strategic adaptations. Although this is a decrease from the 107,236 passengers flown in the same month in the previous year, this is largely attributed to a 17%...

Continue Reading
Exciting Drilling Results from U.S. GoldMining's Whistler Project

Updated Category News Views 101

U.S. GoldMining Reports Drilling Success at Whistler Project U.S. GoldMining Inc. (NASDAQ: USGO) has recently revealed initial results from its drilling activities at the Whistler Gold-Copper Project. This exciting announcement highlights the results from the first two diamond drill holes of the 2024 program. The drilling aims to expand on the previously identified...

Continue Reading
Trados Studio 2026: AI Innovations Elevate Translation

Updated Category News Views 82

Revolutionizing Translation: The Trados Studio 2026 Release It's barely out of the gate, and Trados Studio 2026 is already stirring the pot in the translation world. RWS, the company behind this game-changer, has loaded it with some serious tech muscle. Imagine turning a sluggish operation into a nimble powerhouse—well, that's the promise with the newest Trados Studio...

Continue Reading
Financial Institutions Innovate with Alternative Credit Data Insights

Updated Category News Views 210

Financial Institutions Innovate with Alternative Credit Data Insights Forty percent of financial institutions report rising delinquencies amid growing economic pressure. Recently, LexisNexis Risk Solutions shared the findings of its groundbreaking study on global consumer lending confidence, illustrating significant changes in how financial institutions assess consumer...

Continue Reading
Careviso Elevates Healthcare Access with Innovative COB Feature

Updated Category News Views 166

Careviso Unveils New Coordination of Benefits Feature Careviso, a leader in healthcare patient access technology, has introduced an innovative Coordination of Benefits (COB) feature in its seeQer platform and API. This feature aims to revolutionize the way healthcare organizations process multiple insurance coverages, ensuring that patients receive the most accurate...

Continue Reading